A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain

Clinical Pharmacology Advances and Applications ◽

10.2147/cpaa.s307464 ◽

2021 ◽

Vol Volume 13 ◽

pp. 91-100

Author(s):

Shefali Thanawala ◽

Rajat Shah ◽

Venkateswarlu Somepalli ◽

KrishnaRaju Venkata Alluri ◽

Prabakaran Desomayanandam ◽

...

Keyword(s):

Knee Pain ◽

Low Dose ◽

Controlled Trial ◽

Healthy Adults ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Chronic Knee Pain ◽

Turmeric Extract

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.736643913.793576811 ◽

2020 ◽

Author(s):

Tak Mao Chan ◽

Susan Yung

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Low Dose ◽

Controlled Trial ◽

Efficacy And Safety ◽

Systemic Lupus ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1088945.542078 ◽

2007 ◽

Author(s):

Jonathan Schapiro

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108987.566149 ◽

2008 ◽

Author(s):

Johann Gudjonsson

Keyword(s):

Monoclonal Antibody ◽

Controlled Trial ◽

Interleukin 12 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958672.793516776 ◽

2016 ◽

Author(s):

Robin Spiller

Keyword(s):

Irritable Bowel Syndrome ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793478299 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718524881.793498396 ◽

2014 ◽

Author(s):

David Daikh

Keyword(s):

Ankylosing Spondylitis ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of a Monthly Buprenorphine Depot Injection for Opioid Use Disorder: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3228895 ◽

2018 ◽

Author(s):

Barbara R. Haight ◽

Susan M. Learned ◽

Celine M. Laffont ◽

Paul J. Fudala ◽

Yue Zhao ◽

...

Keyword(s):

Controlled Trial ◽

Opioid Use Disorder ◽

Efficacy And Safety ◽

Opioid Use ◽

Double Blind ◽

Double Blind Placebo ◽

Depot Injection

Download Full-text

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

BMJ ◽

10.1136/bmj.328.7441.686-b ◽

2004 ◽

Vol 328 (7441) ◽

pp. 686.3

Keyword(s):

Type 2 Diabetes ◽

Low Dose ◽

Controlled Trial ◽

Urinary Albumin ◽

Double Blind ◽

Double Blind Placebo ◽

Renal Outcomes

Download Full-text

Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial

EP Europace ◽

10.1093/europace/eur416 ◽

2012 ◽

Vol 14 (6) ◽

pp. 804-809 ◽

Cited By ~ 118

Author(s):

A. J. Camm ◽

E. Toft ◽

C. Torp-Pedersen ◽

P. Vijayaraman ◽

S. Juul-Moller ◽

...

Keyword(s):

Atrial Flutter ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Urology ◽

10.1016/j.urology.2021.01.018 ◽

2021 ◽

Author(s):

Kai Zhang ◽

Yuexin Liu ◽

Wenbo Yang ◽

Jiaji Wang ◽

Jianlin Yang ◽

...

Keyword(s):

Pelvic Pain ◽

Chronic Prostatitis ◽

Chronic Pelvic Pain ◽

Controlled Trial ◽

Chronic Pelvic Pain Syndrome ◽

Pain Syndrome ◽

Pelvic Pain Syndrome ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text